MedTrace Logo

Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalised Prostate Cancer Survivorship Care.

NCT03207113 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 610

Last updated 2017-10-12

No results posted yet for this study

Summary

The Ned case study is a 12-month mixed methods embedded single-case study with a nested within-group pre-post comparison of health outcomes. 400 patients, 200 caregivers, and 10 clinicians will be given access to Ned. Participants will be asked to complete study assessments at baseline, 2 months, 6 months and 12 months. 30 semi-structured qualitative interviews with patients (n=20) and their caregivers (n=10) post-study will also be conducted to gain insight into their experience with the application.

Conditions

Interventions

BEHAVIORAL

Ned

Prostate cancer survivorship application.

Sponsors & Collaborators

  • Trillium Health Partners

    collaborator OTHER

  • University Health Network, Toronto

    collaborator OTHER

  • Centre for Global eHealth Innovation

    lead OTHER

Principal Investigators

  • Andrew Feifer, MD, MPH · Trillium Health Partners

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-31
Primary Completion
2018-03-31
Completion
2019-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03207113 on ClinicalTrials.gov